Management of systemic lupus erythematosus: Part 1.
This is the first of two articles examining the management of systemic lupus erythematosus. This week's article explores the history, aetiology, symptoms and treatment of the disease and next week, the importance of patient education programmes is described.
Crofts
P
P
Department of Rheuamology, Royal Hospitals NHS Trust, London.
D'Cruz
D
D
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D015995:Prevalence; D012307:Risk Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D007166:Immunosuppressive Agents